238 related articles for article (PubMed ID: 28761687)
1. Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts.
Volkmann ER; Hoffmann-Vold AM; Chang YL; Jacobs JP; Tillisch K; Mayer EA; Clements PJ; Hov JR; Kummen M; Midtvedt Ø; Lagishetty V; Chang L; Labus JS; Molberg Ø; Braun J
BMJ Open Gastroenterol; 2017; 4(1):e000134. PubMed ID: 28761687
[TBL] [Abstract][Full Text] [Related]
2. Disease Features and Gastrointestinal Microbial Composition in Patients with Systemic Sclerosis from Two Independent Cohorts.
Andréasson K; Lee SM; Lagishetty V; Wu M; Howlett N; English J; Hesselstrand R; Clements PJ; Jacobs JP; Volkmann ER
ACR Open Rheumatol; 2022 May; 4(5):417-425. PubMed ID: 35174673
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal Characterisation of the Gastrointestinal Tract Microbiome in Systemic Sclerosis.
Volkmann ER; Hoffmann-Vold AM; Chang YL; Lagishetty V; Clements PJ; Midtvedt Ø; Molberg Ø; Braun J; Jacobs JP
Eur Med J (Chelmsf); 2020 Dec; 7():110-118. PubMed ID: 36711108
[TBL] [Abstract][Full Text] [Related]
4. Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium.
Volkmann ER; Chang YL; Barroso N; Furst DE; Clements PJ; Gorn AH; Roth BE; Conklin JL; Getzug T; Borneman J; McGovern DP; Tong M; Jacobs JP; Braun J
Arthritis Rheumatol; 2016 Jun; 68(6):1483-92. PubMed ID: 26749064
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal tract involvement in systemic sclerosis: The roles of diet and the microbiome.
Nguyen AD; Andréasson K; McMahan ZH; Bukiri H; Howlett N; Lagishetty V; Lee SM; Jacobs JP; Volkmann ER
Semin Arthritis Rheum; 2023 Jun; 60():152185. PubMed ID: 36870237
[TBL] [Abstract][Full Text] [Related]
6. Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis.
Zampatti N; Garaiman A; Jordan S; Dobrota R; Becker MO; Maurer B; Distler O; Mihai C
Arthritis Res Ther; 2021 Apr; 23(1):125. PubMed ID: 33888149
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of the University of California Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal tract 2.0 (UCLA-SCTC-GIT 2.0)to change in scleroderma patients.
Suliman YA; Kafaja S; Alemam M; Shaweesh Y; Tavakoli K; Furst DE
J Scleroderma Relat Disord; 2021 Oct; 6(3):236-241. PubMed ID: 35387210
[TBL] [Abstract][Full Text] [Related]
8. Reliability and validity of the Korean version of the University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract instrument in patients with systemic sclerosis.
Lee TH; Lee JS; Park S; Lee KA; Kim HS
Korean J Intern Med; 2021 Nov; 36(6):1504-1514. PubMed ID: 33561335
[TBL] [Abstract][Full Text] [Related]
9. High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in Systemic Sclerosis.
Abozaid HSM; Imam HMK; Abdelaziz MM; El-Hammady DH; Fathi NA; Furst DE
Semin Arthritis Rheum; 2017 Dec; 47(3):403-408. PubMed ID: 28624173
[TBL] [Abstract][Full Text] [Related]
10. Symptoms related to gastrointestinal tract involvement and low muscularity in systemic sclerosis.
Rosato E; Gigante A; Pellicano C; Villa A; Iannazzo F; Alunni Fegatelli D; Muscaritoli M
Clin Rheumatol; 2022 Jun; 41(6):1687-1696. PubMed ID: 35149929
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal symptom severity and progression in systemic sclerosis.
van Leeuwen NM; Boonstra M; Fretheim H; Brunborg C; Midtvedt Ø; Garen T; Molberg Ø; Huizinga TWJ; de Vries-Bouwstra JK; Hoffman-Vold AM
Rheumatology (Oxford); 2022 Oct; 61(10):4024-4034. PubMed ID: 35238377
[TBL] [Abstract][Full Text] [Related]
12. Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
Khanna D; Hays RD; Maranian P; Seibold JR; Impens A; Mayes MD; Clements PJ; Getzug T; Fathi N; Bechtel A; Furst DE
Arthritis Rheum; 2009 Sep; 61(9):1257-63. PubMed ID: 19714600
[TBL] [Abstract][Full Text] [Related]
13. Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis.
Bodukam V; Hays RD; Maranian P; Furst DE; Seibold JR; Impens A; Mayes MD; Clements PJ; Khanna D
Rheumatology (Oxford); 2011 Feb; 50(2):330-4. PubMed ID: 20884655
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial.
Hoffmann-Vold AM; Fretheim HH; Sarna VK; Barua I; Carstens MN; Distler O; Khanna D; Volkmann ER; Midtvedt Ø; Didriksen H; Dhainaut A; Halse AK; Bakland G; Pesonen M; Olsen I; Molberg Ø
BMJ Open; 2021 Jun; 11(6):e048541. PubMed ID: 34168032
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional study using the University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Tract Instrument 2.0 (UCLA SCTC GIT 2.0) for gastrointestinal disorders of systemic sclerosis.
Hisada S; Takeuchi S; Tozawa T; Yamada Y; Ito Y; Kodera M
J Dermatol; 2024 Jul; ():. PubMed ID: 38963343
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal tract microbiota modifications in systemic sclerosis.
Volkmann ER; Hoffmann-Vold AM
Eur J Rheumatol; 2020 Oct; 7(Suppl 3):S228-S236. PubMed ID: 31922474
[TBL] [Abstract][Full Text] [Related]
17. Validation of Serbian version of UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in 104 patients with systemic sclerosis.
Zekovic A; Damjanov N
Rheumatol Int; 2017 May; 37(5):735-741. PubMed ID: 28271157
[TBL] [Abstract][Full Text] [Related]
18. UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis.
Abignano G; Mennillo GA; Lettieri G; Karadag DT; Carriero A; Padula AA; Del Galdo F; Khanna D; D'Angelo S
J Rheumatol; 2021 Sep; 48(9):1422-1426. PubMed ID: 33452163
[TBL] [Abstract][Full Text] [Related]
19. Intestinal microbiome in scleroderma: recent progress.
Volkmann ER
Curr Opin Rheumatol; 2017 Nov; 29(6):553-560. PubMed ID: 28719392
[TBL] [Abstract][Full Text] [Related]
20. Translation, cross-cultural adaptation, and validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument (SCTC GIT) 2.0 into Dutch.
Meijs J; Pors D; Vliet Vlieland TP; Huizinga TW; Schouffoer AA
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-41-8. PubMed ID: 24984228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
